Our goal is to become a global leading manufacturer of a broad range of nanomaterials by producing them at far lower prices than existing suppliers and technologies.
This can be achieved only by Irilliant’s novel and disruptive manufacturing processes that will generate a paradigm shift in the field.
The tremendous cost reduction of nanomaterials (due to disruptive manufacturing processes) will further spur innovation as it will enable product designers to envision their use in consumer products and a wide range of other applications for the first time, and then bring these superior, next-generation products to market.
What we do:
The company’s technical mission is to commercialize several novel processes of synthesis of nanomaterials, including a Chemical Aerosol-Flow Synthesis (CAFS) that was licensed from the University of Illinois Urbana-Champaign (UIUC). Other disruptive methods of synthesis are also being pursued and are patent pending.
Irilliant’s technology focus is to commercialize these proprietary technologies for the efficient and inexpensive production of nanomaterials for next generation thin film photovoltaics, (i.e. CIGS nano-inks), nanomaterials for advanced nanomedicine applications, (i.e. MRI, hyperthermia, antimicrobial coatings, and non-toxic optical imaging modalities), and nanomaterials for next generation displays.
Where we came from:
Irilliant is the result of a collaboration between Oramic LabsTM, the technology incubator of
Oramic, LLC (a Silicon Valley technology innovator) and Dr. Yuri Didenko (the CTO of the company). The company is headquartered in Mountain View, CA and maintains state-of-the-art laboratory facilities in both Mountain View CA, as well as the technology incubator park of UIUC in Champaign, IL. Manufacturing is also maintained in Champaign, IL.
Irilliant continues to benefit from strong links with the University of Illinois. Irilliant’s location at the incubator park of UIUC affords the company access to the technical resources and expertise of the Chemistry, Materials Science, Physics and Life Sciences departments.
Demand for nanoparticles comes from diverse industries, and is growing. Since CAFS is a continuous and simple method of synthesis, the cost of manufacturing equipment, its service, and ultimately, the cost of the final product will be much lower than is possible via competitive batch methods of production.
The flexibility of the CAFS technology also allows the company versatility in switching from the synthesis of one product to another. The flexibility in the variety of products that can be manufactured enables a diverse product portfolio and strengthens our position in the market, but also attracts other application manufacturers interested in licensing our technology.
Our nanomaterials have direct application in a variety of diverse technology sectors from biology and medicine to flat panel displays, memory storage, photovoltaics, and renewable energy
Our nanomaterials have direct application in a variety of diverse technology sectors from biology and medicine to flat panel displays, memory storage, photovoltaics, and renewable energy.